The leading exporters of ambergris, civet, and musk for pharmaceutical use show Brazil as the dominant force, accounting for over twice the export value of its nearest competitor, the United States. Hong Kong follows closely, with Russia and Colombia rounding out the top five. Over recent years, Brazil has exhibited strong export growth largely due to its vast biotic resources and favorable government policies encouraging pharmaceutical industries. In contrast, while figures in the United States and others have seen moderate growth, fluctuations highlight varied market demands and environmental considerations limiting the supply chain.
Future trends to watch include:
- The impact of synthetic alternatives reducing reliance on natural sources.
- Increased regulatory scrutiny on the ethical sourcing of animal-derived products.
- Potential growth in Asia-Pacific markets due to expanding pharmaceutical industries.
Top countries in Top Exporters of Ambergris, Civet, Musk for Pharmaceutical Use
| # | 10 Countries | Million US Dollars | Last Year | |
|---|---|---|---|---|
| 1 | 1 Brazil | 35.96 | 2016 | |
| 2 | 2 United States | 16.11 | 2016 | |
| 3 | 3 Hong Kong | 14.38 | 2016 | |
| 4 | 4 Russia | 11.87 | 2016 | |
| 5 | 5 Colombia | 9.58 | 2016 | |
| 6 | 6 Australia | 7.58 | 2016 | |
| 7 | 7 Canada | 5.61 | 2016 | |
| 8 | 8 New Zealand | 5.6 | 2016 | |
| 9 | 9 India | 5.1 | 2016 | |
| 10 | 10 Uruguay | 5.08 | 2016 |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...